Kura Oncology Inc

KURANASDAQ · USD
10.68USD-0.03 (-0.33%)
157

Kura Oncology Inc (KURA) Unusual Options Activity Today

KURA options volume power reached 5.08x on the previous trading day. The highest reading was on the $11 PUT expiring 2027-04-16.

Read more

Checking KURA unusual options activity helps you spot when traders are making outsized bets on Kura Oncology Inc before the broader market catches on. Kura Oncology Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor KURA unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching KURA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking KURA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and KURA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications.

The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

Catalysts rarely arrive without a footprint, and KURA unusual options activity is often where that footprint shows up first. Our scanner tracks Kura Oncology Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at KURA unusual options volume on the call side or chasing put sweeps, Kura Oncology Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
10.000.401.751.0876%12048424.79%
8.000.754.902.83111%4520322.17%
13.000.050.450.25103%229652.28%
12.00—0.250.2576%181,1761.53%
11.00—1.051.05132%11650.61%
Puts
12.000.652.501.5883%101685.95%
1.00—0.050.05630%00—
2.00—0.050.05440%00—
3.00—0.050.05336%00—
4.00—4.304.301,000%00—

As of September 30, 2026

Spot unusual options activity before it moves

Track KURA options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial